RA
VRTX icon

Rational Advisors’s Vertex Pharmaceuticals VRTX Stock Holding History

Rational Advisors’s Portfolio VRTX Stock Details VRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$37.5K Hold
84
– – ﹤0.01% 130
2025
Q4 		$38.1K Buy
84
+10
+14% +$4.31K ﹤0.01% 137
2025
Q3 		$29K Buy
74
+2
+3% +$836 ﹤0.01% 150
2025
Q2 		$32.1K Buy
+72
New +$33.2K ﹤0.01% 148
2023
Q4 		– Sell
-641
Closed -$223K – 275
2023
Q3 		$223K Buy
641
+259
+68% +$90.6K 0.02% 112
2023
Q2 		$134K Buy
+382
New +$129K 0.01% 135
2020
Q4 		– Sell
-23
Closed -$6K – 591
2020
Q3 		$6K Buy
23
+4
+21% +$1.1K ﹤0.01% 357
2020
Q2 		$6K Buy
+19
New +$5.15K ﹤0.01% 416
2020
Q1 		– Sell
-927
Closed -$203K – 512
2019
Q4 		$203K Buy
927
+833
+886% +$169K 0.1% 187
2019
Q3 		$16K Sell
94
-4,249
-98% -$752K 0.01% 472
2019
Q2 		$797K Buy
4,343
+1,517
+54% +$265K 0.28% 122
2019
Q1 		$520K Buy
+2,826
New +$522K 0.14% 144
2018
Q4 		– Sell
-104
Closed -$20K – 573
2018
Q3 		$20K Buy
104
+100
+2,500% +$17.8K ﹤0.01% 360
2018
Q2 		$1K Sell
4
-82
-95% -$12.7K ﹤0.01% 494
2018
Q1 		$14K Buy
+86
New +$14K 0.01% 353
2015
Q3 		$6K Hold
54
– – ﹤0.01% 391
2015
Q2 		$7K Hold
54
– – ﹤0.01% 396
2015
Q1 		$6K Sell
54
-36
-40% -$4.31K ﹤0.01% 413
2014
Q4 		$11K Buy
+90
New +$10.1K ﹤0.01% 420
2013
Q4 		$351K Sell
4,727
-569
-11% -$39.6K 0.03% 396
2013
Q3 		$402K Sell
5,296
-52
-1% -$4.14K 0.03% 411
2013
Q2 		$428K Buy
+5,348
New +$394K 0.04% 397

Other funds holding VRTX

Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Rational Advisors's VRTX Position: Q1 2026 in Review

Rational Advisors held its Vertex Pharmaceuticals (VRTX) position steady in Q1 2026 at 84 shares worth $37.5K. The position accounts for ﹤0.01% of the portfolio, ranked #130.

Rational Advisors first reported a position in VRTX in Q2 2013 and has held it in 22 quarters since. The position peaked at $797K in Q2 2019. 1,687 funds tracked by Wall St. Rank hold VRTX as of Q1 2026.

  • Rational Advisors held 84 shares of Vertex Pharmaceuticals worth $37.5K as of Q1 2026.
  • Rational Advisors left its Vertex Pharmaceuticals share count unchanged in Q1 2026.
  • Vertex Pharmaceuticals made up ﹤0.01% of Rational Advisors's portfolio in Q1 2026, its #130 holding.
  • Rational Advisors first reported a position in Vertex Pharmaceuticals in Q2 2013 and has held it in 22 quarters since.
  • Rational Advisors's Vertex Pharmaceuticals position peaked at $797K in Q2 2019.
  • 1,687 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q1 2026.

Based on Rational Advisors's 13F filing for Q1 2026, filed 7 May 2026.